RxDoctor Payments Data
★ My doctorsLook up a doctor →

Raphaella Daggett

Family · Putnam, CTNPI 1922529098

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,486 of the $6,117 with a category attached, or 89.7%. It is spread thinly across 54 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,117in general payments, 2019–2025

Across 291 payments — averaging $21.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$756
  • AstraZeneca$394
  • Astellas Pharma US Inc$390
  • AbbVie$324
  • Pfizer$323
  • Incyte Corporation$298
  • plus $4K from 48 others

What the payments were for

  • Food & beverage$5,48690%
  • Education$63110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)35$756
AstraZeneca20$394
Astellas Pharma US Inc8$390
AbbVie17$324
Pfizer18$323
Incyte Corporation13$298
Rigel Pharmaceuticals, Inc.17$279
Bristol Myers Squibb13$276
Bayer10$264
Novartis12$241
Pharmacyclics LLC, An Abbvie Company8$175
Merck7$142
GSK5$131
Eisai Inc.6$125
Sanofi7$120
Lilly USA, LLC7$118
Pharmaessentia USA Corporation5$115
AVEO Pharmaceuticals, Inc.4$112
Array Biopharma Inc5$103
Genentech USA, Inc.5$96
Ipsen Biopharmaceuticals, Inc4$95
Amgen6$93
Stemline Therapeutics Inc.5$89
Coherus Oncology, Inc.3$88
Takeda Pharmaceuticals U.S.A., Inc.4$86
Gilead(2 entities)4$80
E.r. Squibb & Sons, L.L.C.4$77
Seagen Inc.4$69
EMD Serono, Inc.3$66
ADC Therapeutics America, Inc.2$51
Beigene USA, Inc.3$49
Exelixis Inc.2$46
Mirati Therapeutics, Inc.2$40
Taiho Oncology, Inc.2$31
Morphosys, US Inc.2$29
Iovance Biotherapeutics, Inc.1$29
Geron Corporation1$28
Servier Pharmaceuticals LLC1$22
Organon1$21
Karyopharm Therapeutics Inc.1$20
CTI Biopharma Corp.1$20
Recordati_rare_diseases_inc.1$19
Foundation Medicine, Inc.1$19
Sobi, Inc1$18
Jazz Pharmaceuticals Inc.1$18
Pharmacosmos Therapeutics Inc.1$18
Epizyme, Inc.1$17
Sun Pharmaceutical Industries Inc.1$17
Myriad Genetic Laboratories, Inc.1$15
AMAG Pharmaceuticals, Inc.1$15
Alnylam Pharmaceuticals Inc.1$14
Agios Pharmaceuticals, Inc.1$14
Regeneron Healthcare Solutions, Inc.1$13
Dova Pharmaceuticals1$12

How this compares

$6,117 in reported general payments places this provider in the 90th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl35$422
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen26$325
Gabapentin13$225
Prochlorperazine Maleate13$159
Prednisone18$70
Alprazolam12$39
Levofloxacin13$23

Paid to pharmacies, not to this prescriber.

Other family in Putnam

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →